The Global Resource For Connecting Buyers and Sellers

Endo Announces Initiation Of Two Pivotal Phase 3 Clinical Trials Of Collagenase Clostridium Histolyticum For The Treatment Of Cellulite

DUBLIN, Feb. 6, 2018 /PRNewswire/ — Endo International plc (NASDAQ: ENDP) today announced the initiation of two identical Phase 3 RELEASE* clinical trials of collagenase clostridium histolyticum (CCH) for the treatment of cellulite. The multicenter, randomized, double-blind,…